KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoodRx Holdings (GDRX) Current Assets (2019 - 2026)

GoodRx Holdings' Current Assets history spans 7 years, with the latest figure at $643.1 million for Q4 2025.

  • On a quarterly basis, Current Assets fell 2.45% to $643.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $643.1 million, a 2.45% decrease, with the full-year FY2025 number at $643.1 million, down 2.45% from a year prior.
  • Current Assets hit $643.1 million in Q4 2025 for GoodRx Holdings, up from $565.5 million in the prior quarter.
  • Over the last five years, Current Assets for GDRX hit a ceiling of $1.1 billion in Q1 2021 and a floor of $540.2 million in Q1 2025.
  • Historically, Current Assets has averaged $838.2 million across 5 years, with a median of $886.2 million in 2022.
  • Biggest five-year swings in Current Assets: grew 10.33% in 2023 and later crashed 35.32% in 2024.
  • Tracing GDRX's Current Assets over 5 years: stood at $1.1 billion in 2021, then dropped by 15.53% to $919.7 million in 2022, then fell by 5.1% to $872.8 million in 2023, then fell by 24.47% to $659.3 million in 2024, then decreased by 2.45% to $643.1 million in 2025.
  • Business Quant data shows Current Assets for GDRX at $643.1 million in Q4 2025, $565.5 million in Q3 2025, and $550.6 million in Q2 2025.